Granules highlighted that the approved tablet is bioequivalent to the Advil® Dual Action with Acetaminophen Tablets, 250 mg/125 mg, manufactured by GlaxoSmithKline Consumer Healthcare Holdings.

Granules’ total ANDA approvals from the US FDA now stands at 64 (62 final and two tentative approvals). The market for pantoprazole tablets in the US is estimated to be about $233 million ...